How might PCSK9 inhibition change this debate?

Topic: Primary cardiovascular prevention: interventions and outcomes
Sponsored by Sanofi Regeneron

About the speaker

Doctor Shaun Goodman

St. Michael's Hospital, Toronto (Canada)
1 presentation
0 follower

5 more presentations in this session

Introduction - New frontiers in cholesterol management in high CV risk patients.

Speaker: Professor D. Bhatt (New York, US)

Thumbnail

How low should LDL-C be lowered? All that matters is how you lower it.

Speaker: Doctor J. Robinson (Iowa, US)

Thumbnail

How low should LDL-C be lowered? All that matters is how low you lower it.

Speaker: Professor K. Ray (London, GB)

Thumbnail

Panel discussion - New frontiers in cholesterol management in high CV risk patients.

Thumbnail

Concluding remarks - New frontiers in cholesterol management in high CV risk patients.

Speaker: Professor J. Zamorano Gomez (Madrid, ES)

Thumbnail

Access the full session

New frontiers in cholesterol management in high cardiovascular risk patients

Speakers: Doctor S. Goodman, Professor D. Bhatt, Doctor J. Robinson, Professor K. Ray, Professor J. Zamorano Gomez
Thumbnail

About the event

Image

ESC CONGRESS 2014

30 August - 3 September 2014

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb